Product Description

Keytruda 100mg/4ml contains Pembrolizumab, an immune checkpoint inhibitor used in the treatment of various advanced cancers. It is supplied as an intravenous injection/infusion, not as tablets.

Product Overview

Product Name: Keytruda 100mg/4ml

Generic Name: Pembrolizumab

Strength: 100mg/4ml

Form: Solution for Intravenous Infusion

Pack Size: 4ml Vial

Used For: Immunotherapy for multiple advanced cancers

Prescription Required: Yes

Ingredients & How They Work

Each vial contains Pembrolizumab 100mg, which blocks the PD-1 pathway, helping the immune system attack cancer cells.

Key Benefits

• Effective immunotherapy for various cancers
• Helps slow or stop cancer progression
• Long-lasting immune response
• Targeted biological therapy
• Hospital-administered treatment

How to Use

Administer intravenously by a qualified healthcare professional according to your oncologist's recommendations.

Side Effects & Precautions

Possible Side Effects

• Fatigue
• Itching
• Diarrhea
• Skin rash
• Immune-related adverse reactions

Precautions

• Close medical supervision is required.
• Routine blood tests and organ function monitoring may be necessary.
• Report signs of immune-related side effects promptly.
• Follow all scheduled oncology appointments.

Storage Instructions

Store at 2°C to 8°C in the original carton. Do not freeze or shake.